Clinical Trials Logo

Lipid Metabolism clinical trials

View clinical trials related to Lipid Metabolism.

Filter by:

NCT ID: NCT02065817 Completed - Lipid Metabolism Clinical Trials

Dose of Labeled Cholesterol for Kinetics: A Pilot Study

Start date: February 2014
Phase: N/A
Study type: Interventional

This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.

NCT ID: NCT01921075 Completed - Lipid Metabolism Clinical Trials

Physiologic Plasticity of Intramyocardial Lipid Storage

Start date: January 2010
Phase: N/A
Study type: Observational

The main goal of the present study was to provide a technical basis for future studies assessing the role of cardiac lipids. More specifically, non-invasive MR-Spectroscopy (MRS) techniques will be used in this study to: 1. assess the methodological reproducibility of MRS-measurements of cardiac lipids in humans 2. investigate physiological variations of cardiac lipids by measuring day-to-day changes under identical conditions 3. determining diurnal variations of cardiac lipids in humans

NCT ID: NCT01779245 Completed - Lipid Metabolism Clinical Trials

Effect of High-calcium Intake on Substrate Metabolism During Exercise

Start date: October 2012
Phase: N/A
Study type: Interventional

A high-calcium intake can accelerate fat loss under energy-restricted diets. Part of this may be due to a shift in substrate metabolism where there is an increase in the rate of fat oxidation. However, whether high-calcium intake can influence substrate metabolism during exercise is not known. Accordingly, we aim to investigate the effect of 2 weeks of high-calcium intake on substrate metabolism during exercise.

NCT ID: NCT01143493 Completed - Lipid Metabolism Clinical Trials

The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease

Start date: September 30, 2010
Phase:
Study type: Observational

Background: - Glucocorticoids are primary stress response hormones released from the adrenal gland when an individual is under stress. Chronic or ongoing elevation of these hormones due to prolonged stress or medical treatments can have numerous harmful effects. Researchers are interested in learning more about how these hormones affect cell growth, development, and death. To study glucocorticoid hormones, researchers plan to use the medication dexamethasone, which affects the parts of cells that respond to glucocorticoid hormones. Objectives: - To study glucocorticoid stress hormones in healthy individuals before and after receiving dexamethasone. Eligibility: - Healthy individuals at least 18 years of age. - Participants must not be using certain medications that may affect the dexamethasone test, including hormonal contraception, steroid-based drugs, and some antidepressants. Design: - This study will require an initial screening visit and a second study visit. The visits are estimated to require about 1 to 2 hours of participation over a period of up to 14 days. - Participants will be screened at visit 1 with a full physical examination and medical history, and an initial blood sample for testing. - For visit 2, participants will be asked to abstain from all food and drinks except for water for 12 hours before the appointment, and will take one tablet of dexamethasone 9 hours before the appointment. - Participants will have a second blood sample taken during visit 2, and will receive a snack after the blood is drawn.

NCT ID: NCT01098968 Completed - Body Composition Clinical Trials

Education and Fitness: EDUFIT Study

EDUFIT
Start date: January 2007
Phase: N/A
Study type: Interventional

EDUFIT is a group-Randomized Controlled Trial specifically designed to enhance physical fitness and other health-related factors in a school setting in adolescents.

NCT ID: NCT00905892 Completed - Obesity Clinical Trials

Metabolic Fate Modifications of Saturated Fats After an Overfeeding

SURNUT
Start date: September 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the partitioning of exogenous lipids in the postprandial period while a study of overfeeding. The method is based on the incorporation of a stable isotopic tracer (d31_palmitic acid, d31_C16) in lipoprotein triglycerides (TG-CHYLOMICRON and TG-VLDL) and in free fatty acids (FFA).

NCT ID: NCT00620360 Completed - Lipid Metabolism Clinical Trials

Acute Effect of Fructose on Lipid Metabolism and Gender Differences

Start date: January 2008
Phase: N/A
Study type: Interventional

It has been widely documented that fructose overfeeding increases plasma triglycerides and hepatic de novo lipogenesis, and impairs insulin sensitivity in healthy male volunteers. The effect of gender on the metabolic responses to fructose remains an important open question, however. The objective of this study is to compare the effect of an acute oral fructose load on carbohydrate and lipid metabolism in healthy young males and females.

NCT ID: NCT00386854 Completed - Inflammation Clinical Trials

Metabolic Study of Concentric and Eccentric Muscle Training

Start date: April 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the metabolic and anti-inflammatory effects of eccentric endurance exercise and to compare them with those of concentric exercise in healthy sedentary individuals.

NCT ID: NCT00227500 Completed - HIV Infections Clinical Trials

Pravastatin for Hyperlipidaemia in HIV.

Start date: July 2001
Phase: Phase 4
Study type: Interventional

This study is a randomised, placebo-controlled study of the effect of treatment with the HMG-CoA reductase inhibitor, pravastatin, in HIV-infected, protease inhibitor treated patients with high serum cholesterol. We hypothesise that pravastatin will result in greater reductions in cholesterol than placebo when used in conjunction with appropriate dietary advice.